A Trial to Assess the Antipsychotic Efficacy of ITI-007
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The study will be conducted as a randomized, double-blind, parallel-group,
placebo-controlled, multi-center study in patients diagnosed with schizophrenia having an
acute exacerbation of psychosis.